359 related articles for article (PubMed ID: 15144574)
1. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
[TBL] [Abstract][Full Text] [Related]
2. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
3. Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates.
Lanciotti J; Song A; Doukas J; Sosnowski B; Pierce G; Gregory R; Wadsworth S; O'Riordan C
Mol Ther; 2003 Jul; 8(1):99-107. PubMed ID: 12842433
[TBL] [Abstract][Full Text] [Related]
4. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
5. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability.
Eto Y; Gao JQ; Sekiguchi F; Kurachi S; Katayama K; Maeda M; Kawasaki K; Mizuguchi H; Hayakawa T; Tsutsumi Y; Mayumi T; Nakagawa S
J Gene Med; 2005 May; 7(5):604-12. PubMed ID: 15543536
[TBL] [Abstract][Full Text] [Related]
6. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
[TBL] [Abstract][Full Text] [Related]
7. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia.
Hofherr SE; Mok H; Gushiken FC; Lopez JA; Barry MA
Hum Gene Ther; 2007 Sep; 18(9):837-48. PubMed ID: 17767399
[TBL] [Abstract][Full Text] [Related]
9. Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.
Lee EM; Hong SH; Lee YJ; Kang YH; Choi KC; Choi SH; Kim IH; Lim SJ
J Cancer Res Clin Oncol; 2004 Mar; 130(3):169-77. PubMed ID: 14677059
[TBL] [Abstract][Full Text] [Related]
10. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
12. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.
Fisher KD; Stallwood Y; Green NK; Ulbrich K; Mautner V; Seymour LW
Gene Ther; 2001 Mar; 8(5):341-8. PubMed ID: 11313809
[TBL] [Abstract][Full Text] [Related]
13. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
[TBL] [Abstract][Full Text] [Related]
14. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC
J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184
[TBL] [Abstract][Full Text] [Related]
15. Targeted adenovirus mediated inhibition of NF-κB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo.
Kułdo JM; Ásgeirsdóttir SA; Zwiers PJ; Bellu AR; Rots MG; Schalk JA; Ogawara KI; Trautwein C; Banas B; Haisma HJ; Molema G; Kamps JA
J Control Release; 2013 Feb; 166(1):57-65. PubMed ID: 23266453
[TBL] [Abstract][Full Text] [Related]
16. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
17. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins.
Qiu C; De Young MB; Finn A; Dichek DA
Hum Gene Ther; 1998 Mar; 9(4):507-20. PubMed ID: 9525312
[TBL] [Abstract][Full Text] [Related]
18. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.
Hay CM; De Leon H; Jafari JD; Jakubczak JL; Mech CA; Hallenbeck PL; Powell SK; Liau G; Stevenson SC
J Vasc Res; 2001; 38(4):315-23. PubMed ID: 11455202
[TBL] [Abstract][Full Text] [Related]
19. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
[TBL] [Abstract][Full Text] [Related]
20. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
